AIxCrypto sells Marizyme note package for $100K cash, royalty, and 4.99% equity in acquirer

AIxCrypto Holdings, Inc.

Sold secured promissory note (~$4.77M principal, 18% interest) and co-development note ($1.75M) from Marizyme to CABG Acquisition Corp.
Cash consideration $100K at closing; 10% royalty on cumulative net revenue over $20M, capped at $5.67M.
Seller receives 4.99% membership interest in new entity (CABG SPV) formed to acquire Marizyme assets; preemptive and registration rights included.
Closing subject to mutual agreement within 90 days; either party may terminate if not closed by then without further liability.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

AIxCrypto Holdings, Inc. entered into Note Purchase Agreement with CABG ACQUISITION CORP. valued at $100,000 (effective 2026-05-12).

Action: entry
Agreement: notes offering
Counterparty: CABG ACQUISITION CORP.
Value: $100,000
Effective: 2026-05-12

Exact text from the filing

On May 12, 2026, the AIxCrypto Holdings, Inc., a Delaware corporation (the “Company”), entered into a note purchase agreement (the “Note Purchase Agreement”) with CABG ACQUISITION CORP. (“Buyer”), pursuant to which the Company agreed to sell, assign, and transfer to the Buyer, all of the Company’s right, title, and interest in the Note Package

View on SEC.gov

Browse all material agreements →

AIxCrypto Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-023124

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.